首页> 外文期刊>International journal of oncology >Bcl2L12 with a BH3-like domain in regulating apoptosis and TMZ-induced autophagy: A prospective combination of ABT-737 and TMZ for treating glioma
【24h】

Bcl2L12 with a BH3-like domain in regulating apoptosis and TMZ-induced autophagy: A prospective combination of ABT-737 and TMZ for treating glioma

机译:具有BH3样结构域的Bcl2L12在调节细胞凋亡和TMZ诱导的自噬中:ABT-737和TMZ的前瞻性组合治疗神经胶质瘤

获取原文
           

摘要

Bcl2L12 as a new member of the Bcl2 family, which contains a BH2 domain and shares a lower amino acid similarity with other Bcl2 family proteins. Bcl2L12 is reported to be involved in apoptosis regulation, but this role remains controversial in different cancer type. Temozolomide (TMZ) is currently used to intervene glioma multiforme (GBM), but an acquired chemotherapeutic resistance maybe occurred due to undesired autophagy. Previous studies uncovered that Bcl2L12 may interact with Bcl-xL and may harbor a BH3-like domain. Therefore, we investigated whether this BH3-like domain is responsible for the Bcl2L12 anti-apoptotic property. Moreover, we tested whether ABT-737, a BH3 mimetic agent, can be combined with TMZ to treat GBM. We aligned Bcl2L12 with Bcl2 family members, compared interacting pattern of BH3 domain and their protein 3D structure. We identified that Bcl2L12 interacts with Bcl-xL and Bcl2 in yeast two-hybrid system. Bcl2L12192-220 was a minimal region for Bcl2L12-Bcl-xL interaction. Five-point mutations with respect to hydrophobic and charge residues were generated to test whether they are the key residue of BH3-like domain. Our data showed that both h1 (L213) and h2 residue (L217) are essential for Bcl2L12 interacting with Bcl2 family proteins. Ectopically expressed h1 or h2 mutant in U87MG cell line resulted in reactivation of cleaved-PARP, caspase-3 and cytochrome?c releasing compared to Bcl2L12 wt group. Implementing ABT-737 combined with TMZ provided a superior effect on apoptosis induction in Bcl2L12 wt group, which effectively reactivated apoptotic markers. Altogether, our findings indicated that Bcl2L12 retains a BH3-like domain, which is important for the Bcl2L12 anti-apoptotic property and TMZ-induced autophagy. Our results basically support the idea of using ABT-737 to counteract the anti-apoptotic role of Bcl2L12 and sensitize drug response of the GBM cells to TMZ.
机译:Bcl2L12是Bcl2家族的新成员,它包含一个BH2结构域,并且与其他Bcl2家族蛋白的氨基酸相似性较低。据报道,Bcl2L12参与细胞凋亡的调控,但在不同类型的癌症中,这一作用仍存在争议。替莫唑胺(TMZ)目前用于干预多形胶质瘤(GBM),但由于不希望的自噬,可能会导致获得性化疗耐药。先前的研究发现,Bcl2L12可能与Bcl-xL相互作用并且可能带有BH3样结构域。因此,我们调查了这种BH3样域是否负责Bcl2L12抗凋亡特性。此外,我们测试了BH3模拟剂ABT-737是否可以与TMZ结合治疗GBM。我们将Bcl2L12与Bcl2家族成员进行了比对,比较了BH3域与其蛋白3D结构的相互作用方式。我们确定Bcl2L12与Bcl-xL和Bcl2在酵母双杂交系统中相互作用。 Bcl2L12192-220是Bcl2L12-Bcl-xL相互作用的最小区域。产生了关于疏水和电荷残基的五点突变,以测试它们是否是BH3样结构域的关键残基。我们的数据显示,h1(L213)和h2残基(L217)都是Bcl2L12与Bcl2家族蛋白相互作用所必需的。与Bcl2L12 wt组相比,U87MG细胞系中异位表达的h1或h2突变体导致裂解的PARP,caspase-3和细胞色素的释放。实施与TMZ结合的ABT-737对Bcl2L12 wt组的凋亡诱导具有优异的效果,从而有效地激活了凋亡标记物。总之,我们的发现表明Bcl2L12保留了BH3样结构域,这对于Bcl2L12的抗凋亡特性和TMZ诱导的自噬很重要。我们的结果基本上支持使用ABT-737抵消Bcl2L12的抗凋亡作用并使GBM细胞对TMZ的药物反应敏感的想法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号